Lipocalin 2 (LCN2) is a promising target for cholangiocarcinoma treatm
- This topic has 0 replies, 1 voice, and was last updated 7 years, 10 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Lipocalin 2 (LCN2) is a promising target for cholangiocarcinoma treatment and bile LCN2 level is a potential cholangiocarcinoma diagnostic marker.
https://www.ncbi.nlm.nih.gov/pubmed/27782193
Viewing 1 post (of 1 total)
- The forum ‘New Developments’ is closed to new topics and replies.